Holen Sie sich die Stockscreener-App
35.37
1.00%
0.35
Handel nachbörslich:
35.37
Schlusskurs vom Vortag:
$35.02
Offen:
$34.6
24-Stunden-Volumen:
10.15M
Relative Volume:
0.79
Marktkapitalisierung:
$17.37B
Einnahmen:
$178.19B
Nettoeinkommen (Verlust:
$2.05B
KGV:
8.7448
EPS:
4.0447
Netto-Cashflow:
$1.08B
1W Leistung:
+3.82%
1M Leistung:
-0.87%
6M Leistung:
-40.90%
1J Leistung:
-43.19%
1-Tages-Spanne:
$34.02
$35.57
1-Wochen-Bereich:
$32.87
$37.57
52-Wochen-Spanne:
$25.07
$66.81
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Vergleichen Sie CNC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
35.37 | 17.21B | 178.19B | 2.05B | 1.08B | 4.0447 |
|
UNH
Unitedhealth Group Inc
|
341.56 | 312.29B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.15 | 97.35B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
317.20 | 71.55B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
244.41 | 65.99B | 211.96B | 6.45B | 3.94B | 22.67 |
|
HUM
Humana Inc
|
278.19 | 34.35B | 123.11B | 1.58B | 2.44B | 13.03 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-07-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Herabstufung | UBS | Buy → Neutral |
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
What MACD trends signal for Centene Corporation stockEntry Point & High Conviction Trade Alerts - newser.com
Will Centene Corporation stock outperform benchmarks2025 Year in Review & Low Drawdown Momentum Ideas - newser.com
Can Centene Corporation stock expand revenue streamsPortfolio Profit Report & Community Supported Trade Ideas - newser.com
Will Centene Corporation stock maintain growth storyWeekly Risk Report & Verified Entry Point Signals - newser.com
Centene (CNC) Receives Updated Hold Rating and Price Target Incr - GuruFocus
Published on: 2025-11-01 02:13:11 - newser.com
Short interest data insights for Centene CorporationJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Goldman Sachs Maintains Centene (CNC) Sell Recommendation - Nasdaq
Centene (CNC): Goldman Sachs Raises Price Target Despite 'Sell' Rating | CNC Stock News - GuruFocus
Centene's (CNC) Buy Rating Reaffirmed at Truist Financial - MarketBeat
Key resistance and support levels for Centene Corporation2025 Macro Impact & Short-Term High Return Strategies - newser.com
Will Centene Corporation stock deliver shareholder valueJobs Report & Expert Curated Trade Setups - newser.com
Centene Corporation $CNC Shares Bought by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
What downside risks could hit Centene Corporation (QEN) stockJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com
Centene Corp. stock outperforms competitors on strong trading day - MSN
How forex fluctuations impact Centene Corporation (QEN) stockJuly 2025 Sector Moves & High Win Rate Trade Tips - newser.com
Will Centene Corporation stock issue positive guidance2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Is Centene Corporation stock positioned for secular growth2025 Short Interest & Low Drawdown Investment Strategies - newser.com
Will Centene Corporation rebound enough to break evenLong Setup & Real-Time Chart Breakout Alerts - newser.com
Should you wait for a breakout in Centene CorporationJuly 2025 Rallies & Technical Pattern Alert System - newser.com
UBS Maintains Centene (CNC) Neutral Recommendation - Nasdaq
UBS Raises Centene (CNC) Price Target to $42; Maintains Neutral Rating | CNC Stock News - GuruFocus
Centene Corp (CNC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Centene lifts annual outlook, aims profit growth in 2026, shares rise - Reuters
Centene Corp. Hits Day High with 12.5% Surge in Strong Intraday Performance - Markets Mojo
Centene (CNC) Climbs 12.5% on Strong FY25 Outlook - MSN
EQT Corp and Centene lead the Bull Strangle watch list for this week - Barchart.com
Centene (CNC) Receives Price Target Upgrade from Truist Securities | CNC Stock News - GuruFocus
Centene Corporation (NYSE:CNC) Q3 2025 Earnings Call Transcript - Insider Monkey
Goldman Sachs raises Centene stock price target to $38 despite Sell rating - Investing.com
Centene Reaches Analyst Target Price - Nasdaq
Centene Corporation $CNC Shares Bought by Whalen Wealth Management Inc. - MarketBeat
Is Centene Corporation stock trading near support levelsJuly 2025 Momentum & Safe Investment Capital Preservation Plans - newser.com
How Strong Q3 Results and Raised Outlook at Centene (CNC) Have Changed Its Investment Story - Yahoo Finance
Can Centene Corporation (QEN) stock survive global slowdownJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
CNC Q3 Deep Dive: Margin Recovery Prioritized Amid Medicaid and Marketplace Adjustments - Barchart.com
Decoding Centene Corp (CNC): A Strategic SWOT Insight - GuruFocus
Centene Corporation Reports Q3 2025 Financial Results - TipRanks
Will Centene Corporation (QEN) stock boost dividends furtherWeekly Risk Report & Stepwise Entry/Exit Trade Alerts - newser.com
Centene: Q3 Earnings Snapshot - CT Insider
Nvidia, Fiserv, Stride, Caterpillar, Micron, Microsoft, Alphabet, Meta, Centene, and More Movers - Barron's
Centene Highlights Efforts to Push Back Against Elevated ABA Spending - Behavioral Health Business
Centene stock up after company reports better-than-expected third quarter - STLtoday.com
Centene posts $6.6B loss amid soaring medical costs and goodwill impairment charge - The Business Journals
Best Healthcare Stocks To Add to Your WatchlistOctober 29th - MarketBeat
Centene Q3 Earnings Beat Estimates on Increasing Premium - Yahoo Finance
Centene reports $6.6B loss as costs, Medicaid pressures grow - Modern Healthcare
Centene (CNC) Surges as Earnings and Guidance Exceed Expectations - GuruFocus
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday - Benzinga
Centene rises on 2025 EPS guidance boost - Seeking Alpha
Centene Corporation Stock (CNC) Opinions on Q3 2025 Earnings Report - Quiver Quantitative
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.30%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):